GSK PLC (GSK)
Clinical trial NCT04641247 updates: 1. completion date: 2026-11-13 → 2026-12-28 2. primary completion date: 2026-11-13 → 2026-12-28 3. enrollment: 30 → 37 participants
Clinical trial NCT04641247 updates: 1. completion date: 2026-11-13 → 2026-12-28 2. primary completion date: 2026-11-13 → 2026-12-28 3. enrollment: 30 → 37 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical